Akido, a Los Angeles, CA-based AI and care supply firm, raised $60M in Collection B funding.
The spherical was led by Oak HC/FT with participation from Greco, SNR, and present buyers Y Combinator, Future Communities Capital, Jeff Dean (Chief Scientist, Google DeepMind & Google Analysis), and the Complete Blood and Most cancers Middle.
The corporate intends to make use of the funds to develop the attain of ScopeAI.
Based in 2015 and led by CEO Prashant Samant, Akido offers a system that mixes synthetic intelligence and empathy to carry healthcare to everybody. Scope AI allows customers to find out environment friendly paths to analysis by figuring out the following finest inquiries to ask throughout a go to, predict the diagnostic imaging or check to offer lacking knowledge for a analysis with the very best accuracy, establish the most secure and simplest medication and procedures amongst the complete spectrum of prospects, stop future well being issues by predicting dangers with excessive precision.
In 2022, the corporate launched Akido Care, a medical community that at present contains practically 100 clinics, providing major and specialty care throughout 26 sub-specialties.
Akido was created out of the College of Southern California’s Digital Well being Lab.
FinSMEs
16/05/2025
